DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
AFELETECAN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
DNA topoisomerase I stabiliser
AFELETECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
IX0QAD6RD2
Molecule Type:
Small molecule
Molecular Formula:
C45H49N7O11S
Molecular Weight:
895.99
AlogP:
2.95
PSA:
237.48
HBD:
6.0
HBA:
#RotB:
13.0
Source:
BURAPITANT
2
Small molecule
Investigational
Unknown
Unknown
Urinary Bladder, Overactive
Neurokinin 1 receptor antagonist
BURAPITANT
×
Maximum Phase:
2
First Approval:
None
UNII:
E35SK332MS
Molecule Type:
Small molecule
Molecular Formula:
C31H35Cl2F6N3O3
Molecular Weight:
682.53
AlogP:
6.94
PSA:
75.87
HBD:
1.0
HBA:
#RotB:
8.0
Source:
AZD8871
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD8871
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEUTARSERINE
2
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
DEUTARSERINE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C3H7NO3
Molecular Weight:
106.1
AlogP:
-1.61
PSA:
83.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
APG115
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Liposarcoma; Lymphoma; Salivary Gland Neoplasms; Leukemia, Lymphoid
Tumour suppressor p53/oncoprotein Mdm2 inhibitor
APG115
×
Maximum Phase:
2
First Approval:
None
UNII:
15QAU0SI9J
Molecule Type:
Small molecule
Molecular Formula:
C34H38Cl2FN3O4
Molecular Weight:
642.6
AlogP:
6.81
PSA:
98.74
HBD:
3.0
HBA:
#RotB:
5.0
Source:
R-112
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase SYK inhibitor
R-112
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELTOPRAZINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTOPRAZINE
×
Maximum Phase:
2
First Approval:
None
UNII:
510M006KO6
Molecule Type:
Small molecule
Molecular Formula:
C12H16N2O2
Molecular Weight:
220.27
AlogP:
0.87
PSA:
33.73
HBD:
1.0
HBA:
#RotB:
1.0
Source:
AZD2066
2
Small molecule
Investigational
Unknown
Unknown
Chronic Pain; Gastroesophageal Reflux; Depressive Disorder, Major; Diabetic Neuropathies; Neuralgia; Pain
Metabotropic glutamate receptor 5 modulator
AZD2066
×
Maximum Phase:
2
First Approval:
None
UNII:
MQ908Y1ZB2
Molecule Type:
Small molecule
Molecular Formula:
C19H16ClN5O2
Molecular Weight:
381.82
AlogP:
4.33
PSA:
78.86
HBD:
0.0
HBA:
#RotB:
5.0
Source:
REVAMILAST
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Asthma
Unknown
REVAMILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
30LE65637T
Molecule Type:
Small molecule
Molecular Formula:
C18H9Cl2F2N3O4
Molecular Weight:
440.19
AlogP:
4.77
PSA:
91.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
AFIMOXIFENE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Intraductal, Noninfiltrating; Mastodynia
Estrogen receptor modulator
AFIMOXIFENE
×
Maximum Phase:
2
First Approval:
None
UNII:
95K54647BZ
Molecule Type:
Small molecule
Molecular Formula:
C26H29NO2
Molecular Weight:
387.52
AlogP:
5.7
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DERENOFYLLINE
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure
Adenosine A1 receptor antagonist
DERENOFYLLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
O1Q96UZ63W
Molecule Type:
Small molecule
Molecular Formula:
C18H20N4O
Molecular Weight:
308.39
AlogP:
3.34
PSA:
73.83
HBD:
3.0
HBA:
#RotB:
3.0
Source:
GSK189254
2
Small molecule
Investigational
Unknown
Unknown
Narcolepsy
Histamine H3 receptor antagonist
GSK189254
×
Maximum Phase:
2
First Approval:
None
UNII:
5T4TX6CO53
Molecule Type:
Small molecule
Molecular Formula:
C21H25N3O2
Molecular Weight:
351.45
AlogP:
3.19
PSA:
54.46
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ALAGEBRIUM CHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Heart Failure; Hypertension
Unknown
ALAGEBRIUM CHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
79QS8K2877
Molecule Type:
Small molecule
Molecular Formula:
C13H14ClNOS
Molecular Weight:
267.78
AlogP:
2.54
PSA:
20.95
HBD:
0.0
HBA:
#RotB:
3.0
Source:
FULACIMSTAT
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Heart Failure; Myocardial Infarction
Chymase inhibitor
FULACIMSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
VIR72PP4ZU
Molecule Type:
Small molecule
Molecular Formula:
C23H16F3N3O6
Molecular Weight:
487.39
AlogP:
2.7
PSA:
116.44
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ACRIDINE
2
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Lung Neoplasms
DNA disrupting agent
ACRIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
42NI1P5Q1X
Molecule Type:
Small molecule
Molecular Formula:
C13H9N
Molecular Weight:
179.22
AlogP:
3.39
PSA:
12.89
HBD:
0.0
HBA:
#RotB:
0.0
Source:
SUTEZOLID
2
Small molecule
Investigational
Unknown
Unknown
Tuberculosis; Tuberculosis, Pulmonary
70S ribosome inhibitor
SUTEZOLID
×
Maximum Phase:
2
First Approval:
None
UNII:
3A71182L8P
Molecule Type:
Small molecule
Molecular Formula:
C16H20FN3O3S
Molecular Weight:
353.42
AlogP:
1.84
PSA:
61.88
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ROVAZOLAC
2
Small molecule
Investigational
Unknown
Unknown
Dermatitis, Atopic
Unknown
ROVAZOLAC
×
Maximum Phase:
2
First Approval:
None
UNII:
W51K389XIL
Molecule Type:
Small molecule
Molecular Formula:
C21H19F3N2O4S
Molecular Weight:
452.45
AlogP:
4.2
PSA:
78.26
HBD:
0.0
HBA:
#RotB:
6.0
Source:
LY2828360
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis, Knee
Cannabinoid CB2 receptor agonist
LY2828360
×
Maximum Phase:
2
First Approval:
None
UNII:
O12H7VFU6P
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SEMAPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Crohn Disease
MAP kinase p38 alpha inhibitor
SEMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
9SGW2H1K8P
Molecule Type:
Small molecule
Molecular Formula:
C34H52N18O2
Molecular Weight:
744.91
AlogP:
2.21
PSA:
355.24
HBD:
14.0
HBA:
#RotB:
19.0
Source:
CABOTEGRAVIR
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Virus Diseases
Human immunodeficiency virus type 1 integrase inhibitor
CABOTEGRAVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
HMH0132Z1Q
Molecule Type:
Small molecule
Molecular Formula:
C19H17F2N3O5
Molecular Weight:
405.36
AlogP:
0.96
PSA:
100.87
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LISOFYLLINE
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1
Unknown
LISOFYLLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
L1F2Q2X956
Molecule Type:
Small molecule
Molecular Formula:
C13H20N4O3
Molecular Weight:
280.33
AlogP:
-0.02
PSA:
82.05
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AXL-1717
2
Small molecule
Investigational
Unknown
Unknown
Astrocytoma; Carcinoma, Non-Small-Cell Lung; Gliosarcoma; Hematologic Neoplasms; Neoplasms; Oligodendroglioma; Adenocarcinoma of Lung; Carcinoma, Squamous Cell
Insulin-like growth factor I receptor inhibitor
AXL-1717
×
Maximum Phase:
2
First Approval:
None
UNII:
0F35AOI227
Molecule Type:
Small molecule
Molecular Formula:
C22H22O8
Molecular Weight:
414.41
AlogP:
2.41
PSA:
92.68
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CELGOSIVIR
2
Small molecule
Investigational
Unknown
Unknown
Dengue; Hepatitis C, Chronic
Alpha glucosidase inhibitor
CELGOSIVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
895VG117HN
Molecule Type:
Small molecule
Molecular Formula:
C12H21NO5
Molecular Weight:
259.3
AlogP:
-1.13
PSA:
90.23
HBD:
3.0
HBA:
#RotB:
3.0
Source:
REBOXETINE MESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
REBOXETINE MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
L94J81YNNY
Molecule Type:
Small molecule
Molecular Formula:
C20H27NO6S
Molecular Weight:
409.5
AlogP:
3.19
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BEDORADRINE SULFATE
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Asthma; Status Asthmaticus
Beta-2 adrenergic receptor agonist
BEDORADRINE SULFATE
×
Maximum Phase:
2
First Approval:
None
UNII:
P875C0DV2V
Molecule Type:
Small molecule
Molecular Formula:
C48H66N4O14S
Molecular Weight:
955.14
AlogP:
1.57
PSA:
102.26
HBD:
4.0
HBA:
#RotB:
9.0
Source:
ALBITIAZOLIUM BROMIDE
2
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
ALBITIAZOLIUM BROMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
3AC0AJ4ILP
Molecule Type:
Small molecule
Molecular Formula:
C24H42Br2N2O2S2
Molecular Weight:
614.55
AlogP:
4.67
PSA:
48.22
HBD:
2.0
HBA:
#RotB:
17.0
Source:
SUCRALOSE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SUCRALOSE
×
Maximum Phase:
2
First Approval:
None
UNII:
96K6UQ3ZD4
Molecule Type:
Small molecule
Molecular Formula:
C12H19Cl3O8
Molecular Weight:
397.64
AlogP:
-1.66
PSA:
128.84
HBD:
5.0
HBA:
#RotB:
5.0
Source:
BORIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Eczema; Periodontitis; Vaginosis, Bacterial; Candidiasis, Vulvovaginal
Unknown
BORIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
R57ZHV85D4
Molecule Type:
Small molecule
Molecular Formula:
H3BO3
Molecular Weight:
61.83
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AZD-1236
2
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis; Pulmonary Disease, Chronic Obstructive
Matrix metalloproteinase 12 inhibitor
AZD-1236
×
Maximum Phase:
2
First Approval:
None
UNII:
B4OQY51WZS
Molecule Type:
Small molecule
Molecular Formula:
C15H19ClN4O5S
Molecular Weight:
402.86
AlogP:
0.51
PSA:
117.7
HBD:
2.0
HBA:
#RotB:
5.0
Source:
NETOGLITAZONE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor gamma modulator
NETOGLITAZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
QOV2JZ647A
Molecule Type:
Small molecule
Molecular Formula:
C21H16FNO3S
Molecular Weight:
381.43
AlogP:
4.45
PSA:
55.4
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AFABICIN
2
Small molecule
Investigational
Unknown
Unknown
Infections
Enoyl-[acyl-carrier-protein] reductase [NADPH] inhibitor
AFABICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
DMM8663H2R
Molecule Type:
Small molecule
Molecular Formula:
C23H24N3O7P
Molecular Weight:
485.43
AlogP:
3.15
PSA:
133.41
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BMS-582949
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Psoriasis; Vascular Diseases
MAP kinase p38 alpha inhibitor
BMS-582949
×
Maximum Phase:
2
First Approval:
None
UNII:
CR743OME9E
Molecule Type:
Small molecule
Molecular Formula:
C22H26N6O2
Molecular Weight:
406.49
AlogP:
3.12
PSA:
100.42
HBD:
3.0
HBA:
#RotB:
7.0
Source:
GEMCABENE
2
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia; Lipid Metabolism Disorders; Non-alcoholic Fatty Liver Disease
Unknown
GEMCABENE
×
Maximum Phase:
2
First Approval:
None
UNII:
B96UX1DDKS
Molecule Type:
Small molecule
Molecular Formula:
C16H30O5
Molecular Weight:
302.41
AlogP:
3.57
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
12.0
Source:
BI-44370
2
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Calcitonin gene-related peptide type 1 receptor antagonist
BI-44370
×
Maximum Phase:
2
First Approval:
None
UNII:
7L3WOA232W
Molecule Type:
Small molecule
Molecular Formula:
C35H47N5O6
Molecular Weight:
633.79
AlogP:
3.93
PSA:
114.89
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ASP8273
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ASP8273
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
127
128
129
130
131
132
133
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA